Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,500.96
    -1,052.55 (-2.04%)
     
  • CMC Crypto 200

    1,304.48
    -92.06 (-6.59%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Company News For Oct 5, 2017

CWCO vs. GWRS: Which Stock Is the Better Value Option?
  • Shares of Pepsico, Inc. PEP gained 0.2% after reporting third quarter 2017 earnings per share of $1.48, surpassing the Zacks Consensus Estimate of $1.43

  • Mattel, Inc.’s MAT shares surged 0.3% after the company announced Joseph Euteneuer as its new Chief Financial Officer

  • Shares of Mylan N.V. MYL rallied 16.2% after the company announced that it had received an approval from Food and Drug Administration for the generic version of multiple sclerosis treatment drug – Copaxone, made by Teva Pharmaceutical Industries Ltd. (TEVA)

  • Office Depot, Inc.’s ODP shares plummeted 17.7% after the company lowered its revenue guidance for 2017 to $400 million — $425 million from $500 million initially


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pepsico, Inc. (PEP) : Free Stock Analysis Report
 
Mylan N.V. (MYL) : Free Stock Analysis Report
 
Office Depot, Inc. (ODP) : Free Stock Analysis Report
 
Mattel, Inc. (MAT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research